Baiyunshan Cefprozil Dispersible Tablets Product Leaflet

Package insert for Baiyunshan Cefprozil Dispersible Tablets detailing composition, dosage, warnings, and storage.


Baiyunshan Cefprozil Dispersible Tablets Product Leaflet - cover page
Brand
Baiyunshan
Document type
Product Leaflet
Language
Chinese
Pages
4
File format
PDF
File size
187 KB
Published
28 September, 2026
Updated
28 September, 2026
MD5 checksum
1276695A289F74328E3BDB70E06656E8

About this manual

This leaflet provides comprehensive information on Cefprozil Dispersible Tablets, including the active ingredient, chemical properties, physical appearance, and approved therapeutic indications such as upper and lower respiratory tract infections and skin infections.

It also covers dosage regimens for different age groups, adjustments for renal impairment, contraindications, possible adverse reactions, drug interactions, pharmacokinetic data, and proper storage and packaging instructions. This manual is written in Chinese.

What's inside

  • Drug Name
  • Composition
  • Physical Description
  • Indications
  • Dosage and Administration
  • Contraindications
  • Precautions
  • Adverse Reactions
  • Pharmacokinetics
  • Storage and Packaging

Specifications

Active ingredientCefprozil
Strength per tablet0.25 g (as cefprozil)
Molecular formulaC18H19N3O5S·H2O
Molecular weight407.45 g/mol
Shelf life24 months
Storage conditionProtect from light, sealed, cool dry place ≤20 °C

Frequently asked questions

What is the recommended dosage for adults with upper respiratory infection?

Adults (13 years and older) should take 0.5 g (2 tablets) once daily for upper respiratory tract infection.

How should the medication be stored?

Store the tablets protected from light, in a sealed container, in a cool dry place not exceeding 20 °C.

What are the common adverse reactions?

Common adverse reactions include gastrointestinal effects such as diarrhea, nausea, vomiting, abdominal pain, and allergic reactions like rash and urticaria.

Download PDF (187 KB)